Healthcare Professional and Patient Surveys to Evaluate the Effectiveness of the Risk Minimisation Educational Materials for Certolizumab Pegol (CZP; CIMZIA®)

29/08/2016
04/03/2024
EU PAS number:
EUPAS14867
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

UP0038-protocol-amend-2-final-redacted

English (2.08 MB - PDF) View document
Study results
Study results

UP0038-bodytext-final-redacted

English (2.02 MB - PDF) View document
Study report
Other information